Application of SR-A as diagnostic marker and intervention target for rheumatoid arthritis
An arthritis and marker technology, applied in the field of clinical medicine, to achieve the effect of good diagnostic specificity, improved detection accuracy, and good treatment effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment l
[0029] Embodiment 1 SR-A is used as the sensitivity and the specificity of marker diagnosis RA
[0030] Based on enzyme-linked immunosorbent assay (i.e., ELISA method), antibodies that specifically recognize class A scavenger receptor proteins (mouse anti-human SR-A monoclonal antibody and HRP-labeled rabbit anti-human SR-A monoclonal antibody, purchased from Beijing Yiqiao Shenzhou Biotechnology Co., Ltd.) and class A scavenger receptor protein standard (Recombinant Human SR-A, American R&D company) were used as diagnostic reagents for RA, osteoarthritis, systemic lupus erythematosus, Sjogren's syndrome and SR-A in normal human serum is detected to evaluate the distribution of SR-A in various diseases and its value in diagnosing RA.
[0031] The reagent combination used to detect the concentration of SR-A protein in the subject's serum sample includes the following components: a class A scavenger receptor protein standard, a capture antibody (capture) that binds to a microtit...
Embodiment 2
[0053] The neutralizing antibody of embodiment 2SR-A inhibits the differentiation of RA monocytes to osteoclasts
[0054] Through in vitro osteoclast induction experiments, the inhibitory effect of SR-A neutralizing antibody on osteoclastogenesis was detected, and the potential value of SR-A as an RA intervention target was evaluated.
[0055] Aseptically isolate PBMC (peripheral blood mononuclear cells) from patients with rheumatoid arthritis, and spread them into 12-well cell culture plates (5×10 5 Cells / well), change the medium after two hours of adherence, keep only the adherent monocytes (osteoclast precursor cells), and add 30ng / mL M-CSF (macrophage colony-stimulating factor) and 25ng / mL ml of RANKL (receptor activator of nuclear factor kappa B ligand).
[0056] 2μg / mL anti-SR-A neutralizing antibody (Mouse anti-human SR-A Neutralization Antibody, American R&D Company) and isotype antibody (Mouse IgG1, American R&D Company) were added to two wells of cells from the same...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com